Cryoport Inc (CYRX) 0.4550 $CYRX
Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015
PR Newswire - Thu Jul 31, 7:00AM CDT
Cryoport, Inc. (OTCBB: CYRX) today announced financial results for the three month period ended June 30, 2014.
Cryoport and DHL Partner to Provide Cryogenic Logistics Solutions for Life Sciences and Healthcare Clients
PR Newswire Europe - Wed Jul 16, 11:07AM CDT
-- DHL adopts "powered by cryoport" cryogenic logistics solution for life sciences
Cryoport Launches Free Investor Relations App
PR Newswire - Tue Jul 01, 7:00AM CDT
Cryoport, Inc. (OTCBB: CYRX) ("the Company"
today announced the release of its investor relations app for iPhone, iPad and Android mobile devices now available for free at Apple's App Store for the iPhone and iPad https://itunes.apple.com/us/app/cryoport-inve...1&mt=8 and at Google Play https://play.google.com/store/apps/details?id...p.cryoport for Android mobile devices.
Immudex Selects Cryoport to Manage Cold Chain Logistics of Biologic Samples and Proficiency Panels Worldwide
PR Newswire - Mon Jun 23, 7:00AM CDT
Cryoport, Inc. (OTCBB: CYRX) ("the Company" today announced that it has been chosen by Immudex to support its global distribution of biological materials and samples for proficiency panels to and from Immudex's production and research facilities and customers.
Cryoport elects Dr Ramkumar Mandalam to board & Compensation and Nominating and Governance Committees
M2 - Tue Jun 17, 6:26AM CDT
Cryogenic logistics company Cryoport (OTC BB:CYRX) reported on Monday the addition of Ramkumar Mandalam PhD, to its board of directors as well as a member of the Compensation and Nominating and Governance Committees.
Cryoport Announces Appointment of Ramkumar Mandalam, Ph.D. to Board of Directors
PR Newswire - Mon Jun 16, 7:00AM CDT
Cryoport, Inc. (OTC BB: CYRX) ("the Company" , the leading, global provider of advanced cryogenic logistics solutions, today announced the appointment of Ramkumar Mandalam, Ph.D., to its Board of Directors. Additionally, he has been appointed to serve as a member of the Compensation and Nominating and Governance Committees. Following Dr. Mandalam's appointment, Cryoport's Board of Directors will have a total of five members, including four independent members.
Cryoport Participates in the Cold Chain BioLogistics Summit on June 16-18th 2014 in San Diego
PR Newswire - Thu Jun 12, 11:20AM CDT
Cryoport, Inc. (OTC BB: CYRX) ("the Company" , the leading provider of advanced cryogenic logistics solutions, today announced that it will be showcasing its patented Cryoport Express® Shippers and its Cryoportal(TM) Logistics Management Platform, a revolutionary, purpose-built technology which manages and monitors the entire cold chain logistics process for biologic materials, at the BioLogistics Summit in San Diego, California, on June 16th-18th.
Cenetron Diagnostics Expands Use of Cryoport's Cryogenic Logistics Solutions to Support Growth of Molecular Laboratory Services
PR Newswire - Thu May 29, 7:00AM CDT
Cryoport, Inc. (OTCBB: CYRX) ("the Company" , the leading provider of advanced cryogenic logistics solutions, today announced that Cenetron Diagnostics has expanded the use of its customized cryogenic logistics solution powered by Cryoport's Cryoportal(TM) and Cryoport Express® Shippers.
Merriman Capital Advisory Clients Presenting at the Third Annual Marcum LLP Microcap Conference
Thomson Reuters ONE - Thu May 22, 8:01AM CDT
SAN FRANCISCO, May 22, 2014 - Merriman Capital, Inc., a wholly owned subsidiary of Merriman Holdings, Inc. (OTCQX: MERR), is pleased to announce the firm's advisory clients that will be presenting at the Third Annual Marcum LLP MicroCap Conference. The conference will be held on Thursday, May 29, 2014 in New York City at the Grand Hyatt Hotel.
Cryoport To Present At Annual Marcum MicroCap Conference
PR Newswire - Thu May 22, 7:00AM CDT
Cryoport, Inc. (OTCBB: CYRX) ("the Company" announced today that it will be a featured presenter at the 3rd Annual Marcum MicroCap Conference on Thursday, May 29, 2014 held at the Grand Hyatt Hotel in New York City.
Cryoport Supports International Clinical Trials for Glaukos Corporation with its Comprehensive Turn-Key Frozen Logistics Solution
PR Newswire - Wed May 21, 7:00AM CDT
Cryoport, Inc. (OTCBB: CYRX) ("the Company" today announced that it is providing its turn-key frozen logistics solution to Glaukos Corporation, an ophthalmic medical device company, in support of the iStent clinical trials, shipping biologic material from Armenia to California.
Cryoport and European Mouse Mutant Archive Enter into Global Agreement to Provide Full-Service Logistics Solutions for Frozen Biomaterials
PR Newswire Europe - Tue Apr 01, 7:01AM CDT
- Critical frozen logistics solution supports shipments of mouse mutant lines to EMMA clients in more than 40 different countries with a focus on Europe and Northern America
Cryoport, Inc. Retains KCSA Strategic Communications as U.S. Investor Relations Counsel
PR Newswire - Thu Mar 27, 8:18AM CDT
Cryoport, Inc. (OTC BB: CYRX), the only end-to-end cryogenic logistics solutions provider, today announced that it has retained KCSA Strategic Communications, a leading New York-based communications firm, to lead the Company's investor relations program.
10-Q: CRYOPORT, INC.
Edgar Online - Thu Feb 13, 12:05PM CST
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
Cryoport Increases Revenues By 149% For The First Nine Months of Fiscal 2014
Business Wire - Thu Feb 13, 5:00AM CST
Cryoport, Inc. (OTCBB: CYRX) today announced financial results for the quarter and nine months ended December 31, 2013.
Liventa Bioscience and Cryoport Form Alliance to Deliver Cell-Based Biologics to Point-of-Service Orthopedic Care
Business Wire - Wed Feb 05, 5:20PM CST
Liventa Bioscience (formerly AFcell Medical) and Cryoport, Inc. (OTC:CYRX) today announced a major strategic alliance aimed at serving the many points of orthopedic care delivery with Liventa's cell-based, advanced biologics tissue forms. The exclusive agreement combines Cryoport's proprietary, purpose-built cold chain logistics solutions for cell-based and advanced biologic tissue forms with Liventa Bioscience's distribution capability to "point-of-use" US-based orthopedic care providers.
Liventa Bioscience and Cryoport form Alliance to deliver cell-based biologics to Point-of-Service Orthopedic Care
PR Newswire - Wed Feb 05, 8:30AM CST
Liventa Bioscience (formerly AFcell Medical) and Cryoport, Inc. (OTC:CYRX) today announced a major strategic alliance aimed at serving the many points of orthopedic care delivery with Liventa's cell-based, advanced biologics tissue forms. The exclusive agreement combines Cryoport's proprietary, purpose-built cold chain logistics solutions for cell based and advanced biologic tissue forms with Liventa Bioscience's distribution capability to "point-of-use" US-based orthopedic care providers.
Cryoport Reports 92% Revenue Growth for First Quarter of Fiscal 2015
PR Newswire - Thu Jul 31, 7:00AM CDT
Cryoport, Inc. (OTCBB: CYRX) today announced financial results for the three month period ended June 30, 2014.
Cryoport and DHL Partner to Provide Cryogenic Logistics Solutions for Life Sciences and Healthcare Clients
PR Newswire Europe - Wed Jul 16, 11:07AM CDT
-- DHL adopts "powered by cryoport" cryogenic logistics solution for life sciences
Cryoport Launches Free Investor Relations App
PR Newswire - Tue Jul 01, 7:00AM CDT
Cryoport, Inc. (OTCBB: CYRX) ("the Company"
today announced the release of its investor relations app for iPhone, iPad and Android mobile devices now available for free at Apple's App Store for the iPhone and iPad https://itunes.apple.com/us/app/cryoport-inve...1&mt=8 and at Google Play https://play.google.com/store/apps/details?id...p.cryoport for Android mobile devices. Immudex Selects Cryoport to Manage Cold Chain Logistics of Biologic Samples and Proficiency Panels Worldwide
PR Newswire - Mon Jun 23, 7:00AM CDT
Cryoport, Inc. (OTCBB: CYRX) ("the Company"
today announced that it has been chosen by Immudex to support its global distribution of biological materials and samples for proficiency panels to and from Immudex's production and research facilities and customers. Cryoport elects Dr Ramkumar Mandalam to board & Compensation and Nominating and Governance Committees
M2 - Tue Jun 17, 6:26AM CDT
Cryogenic logistics company Cryoport (OTC BB:CYRX) reported on Monday the addition of Ramkumar Mandalam PhD, to its board of directors as well as a member of the Compensation and Nominating and Governance Committees.
Cryoport Announces Appointment of Ramkumar Mandalam, Ph.D. to Board of Directors
PR Newswire - Mon Jun 16, 7:00AM CDT
Cryoport, Inc. (OTC BB: CYRX) ("the Company"
, the leading, global provider of advanced cryogenic logistics solutions, today announced the appointment of Ramkumar Mandalam, Ph.D., to its Board of Directors. Additionally, he has been appointed to serve as a member of the Compensation and Nominating and Governance Committees. Following Dr. Mandalam's appointment, Cryoport's Board of Directors will have a total of five members, including four independent members. Cryoport Participates in the Cold Chain BioLogistics Summit on June 16-18th 2014 in San Diego
PR Newswire - Thu Jun 12, 11:20AM CDT
Cryoport, Inc. (OTC BB: CYRX) ("the Company"
, the leading provider of advanced cryogenic logistics solutions, today announced that it will be showcasing its patented Cryoport Express® Shippers and its Cryoportal(TM) Logistics Management Platform, a revolutionary, purpose-built technology which manages and monitors the entire cold chain logistics process for biologic materials, at the BioLogistics Summit in San Diego, California, on June 16th-18th. Cenetron Diagnostics Expands Use of Cryoport's Cryogenic Logistics Solutions to Support Growth of Molecular Laboratory Services
PR Newswire - Thu May 29, 7:00AM CDT
Cryoport, Inc. (OTCBB: CYRX) ("the Company"
, the leading provider of advanced cryogenic logistics solutions, today announced that Cenetron Diagnostics has expanded the use of its customized cryogenic logistics solution powered by Cryoport's Cryoportal(TM) and Cryoport Express® Shippers. Merriman Capital Advisory Clients Presenting at the Third Annual Marcum LLP Microcap Conference
Thomson Reuters ONE - Thu May 22, 8:01AM CDT
SAN FRANCISCO, May 22, 2014 - Merriman Capital, Inc., a wholly owned subsidiary of Merriman Holdings, Inc. (OTCQX: MERR), is pleased to announce the firm's advisory clients that will be presenting at the Third Annual Marcum LLP MicroCap Conference. The conference will be held on Thursday, May 29, 2014 in New York City at the Grand Hyatt Hotel.
Cryoport To Present At Annual Marcum MicroCap Conference
PR Newswire - Thu May 22, 7:00AM CDT
Cryoport, Inc. (OTCBB: CYRX) ("the Company"
announced today that it will be a featured presenter at the 3rd Annual Marcum MicroCap Conference on Thursday, May 29, 2014 held at the Grand Hyatt Hotel in New York City. Cryoport Supports International Clinical Trials for Glaukos Corporation with its Comprehensive Turn-Key Frozen Logistics Solution
PR Newswire - Wed May 21, 7:00AM CDT
Cryoport, Inc. (OTCBB: CYRX) ("the Company"
today announced that it is providing its turn-key frozen logistics solution to Glaukos Corporation, an ophthalmic medical device company, in support of the iStent clinical trials, shipping biologic material from Armenia to California. Cryoport and European Mouse Mutant Archive Enter into Global Agreement to Provide Full-Service Logistics Solutions for Frozen Biomaterials
PR Newswire Europe - Tue Apr 01, 7:01AM CDT
- Critical frozen logistics solution supports shipments of mouse mutant lines to EMMA clients in more than 40 different countries with a focus on Europe and Northern America
Cryoport, Inc. Retains KCSA Strategic Communications as U.S. Investor Relations Counsel
PR Newswire - Thu Mar 27, 8:18AM CDT
Cryoport, Inc. (OTC BB: CYRX), the only end-to-end cryogenic logistics solutions provider, today announced that it has retained KCSA Strategic Communications, a leading New York-based communications firm, to lead the Company's investor relations program.
10-Q: CRYOPORT, INC.
Edgar Online - Thu Feb 13, 12:05PM CST
ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.
Cryoport Increases Revenues By 149% For The First Nine Months of Fiscal 2014
Business Wire - Thu Feb 13, 5:00AM CST
Cryoport, Inc. (OTCBB: CYRX) today announced financial results for the quarter and nine months ended December 31, 2013.
Liventa Bioscience and Cryoport Form Alliance to Deliver Cell-Based Biologics to Point-of-Service Orthopedic Care
Business Wire - Wed Feb 05, 5:20PM CST
Liventa Bioscience (formerly AFcell Medical) and Cryoport, Inc. (OTC:CYRX) today announced a major strategic alliance aimed at serving the many points of orthopedic care delivery with Liventa's cell-based, advanced biologics tissue forms. The exclusive agreement combines Cryoport's proprietary, purpose-built cold chain logistics solutions for cell-based and advanced biologic tissue forms with Liventa Bioscience's distribution capability to "point-of-use" US-based orthopedic care providers.
Liventa Bioscience and Cryoport form Alliance to deliver cell-based biologics to Point-of-Service Orthopedic Care
PR Newswire - Wed Feb 05, 8:30AM CST
Liventa Bioscience (formerly AFcell Medical) and Cryoport, Inc. (OTC:CYRX) today announced a major strategic alliance aimed at serving the many points of orthopedic care delivery with Liventa's cell-based, advanced biologics tissue forms. The exclusive agreement combines Cryoport's proprietary, purpose-built cold chain logistics solutions for cell based and advanced biologic tissue forms with Liventa Bioscience's distribution capability to "point-of-use" US-based orthopedic care providers.
